Journal
EMBO JOURNAL
Volume 28, Issue 8, Pages 1055-1066Publisher
WILEY
DOI: 10.1038/emboj.2009.55
Keywords
degradation; methylation; RelA; Set9
Categories
Funding
- American Lung Association
- Arthritis Foundation Investigator Award
Ask authors/readers for more resources
Proper regulation of NF-kappa B activity is critical to maintain and balance the inflammatory response. Inactivation of the NF-kappa B complex relies in part on the proteasome-mediated degradation of promoter-bound NF-kappa B, but the detailed molecular mechanism initiating this process remains elusive. Here, we show that the methylation of the RelA subunit of NF-kappa B has an important function in this process. Lysine methyltransferase Set9 physically associates with RelA in vitro and in vivo in response to TNF-alpha stimulation. Mutational and mass spectrometric analyses reveal that RelA is monomethylated by Set9 at lysine residues 314 and 315 in vitro and in vivo. Methylation of RelA inhibits NF-kappa B action by inducing the proteasome-mediated degradation of promoter-associated RelA. Depletion of Set9 by siRNA or mutation of the RelA methylation sites prolongs DNA binding of NF-kappa B and enhances TNF-alpha-induced expression of NF-kappa B target genes. Together, these findings unveil a novel mechanism by which methylation of RelA dictates the turnover of NF-kappa B and controls the NF-kappa B-mediated inflammatory response.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available